ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1

Annalisa Perna; Piero Ruggenenti; A. Testa; Belinda Spoto; Roberto Benini; V. Misefari; Giuseppe Remuzzi; Carmine Zoccali

doi:10.1046/j.1523-1755.2000.00818.x

Related publications

Article2017

ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal disease

Norberto Perico, Piero Ruggenenti, Giuseppe Remuzzi

Article2024

Tubulointerstitial injury in proteinuric chronic kidney diseases

Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi

Article2004

ACE Genotype and Endurance Performance Level in Hispanic Marathon Runners

Mireya Bolo, Dannaly Reyes, Cristina Mart nez, Juan L. Mart nez-Barreda, José Antonio Martín Urrialde, Juan López-Taylor, Marcos Echegaray, Claude Bouchard, Miguel A. Rivera

Medicine & Science in Sports & Exercise

Article2004

ACE Genotype and Endurance Performance Level in Hispanic Marathon Runners

Mireya Bolo, Dannaly Reyes, Cristina Martínez, Juan L. Martínez-Barreda, José Antonio Martín Urrialde, Juan López-Taylor, Marcos Echegaray, Claude Bouchard, Miguel A. Rivera

Medicine & Science in Sports & Exercise

Article1996

[ACE-inhibitors in acute heart infarct].

Michele Genoni, G Garzoli, Markus Pfister, Patrick T. Siegrist, Roberto Malacrida, Aldo Maggioni, Tiziano Moccetti

ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1

Discussion(0)

Related publications

ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal disease

Tubulointerstitial injury in proteinuric chronic kidney diseases

ACE Genotype and Endurance Performance Level in Hispanic Marathon Runners

ACE Genotype and Endurance Performance Level in Hispanic Marathon Runners

[ACE-inhibitors in acute heart infarct].